GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AngioLab Inc (XKRX:251280) » Definitions » EV-to-Revenue

AngioLab (XKRX:251280) EV-to-Revenue : 30.78 (As of May. 26, 2024)


View and export this data going back to 2016. Start your Free Trial

What is AngioLab EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, AngioLab's enterprise value is ₩15,289.2 Mil. AngioLab's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₩496.6 Mil. Therefore, AngioLab's EV-to-Revenue for today is 30.78.

The historical rank and industry rank for AngioLab's EV-to-Revenue or its related term are showing as below:

XKRX:251280' s EV-to-Revenue Range Over the Past 10 Years
Min: 2.34   Med: 17.68   Max: 103.6
Current: 30.78

During the past 7 years, the highest EV-to-Revenue of AngioLab was 103.60. The lowest was 2.34. And the median was 17.68.

XKRX:251280's EV-to-Revenue is ranked worse than
72.28% of 1039 companies
in the Biotechnology industry
Industry Median: 8.18 vs XKRX:251280: 30.78

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-26), AngioLab's stock price is ₩6000.00. AngioLab's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₩178.27. Therefore, AngioLab's PS Ratio for today is 33.66.

AngioLab EV-to-Revenue Historical Data

The historical data trend for AngioLab's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AngioLab EV-to-Revenue Chart

AngioLab Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial 19.81 90.79 22.52 20.71 40.01

AngioLab Semi-Annual Data
Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue Get a 7-Day Free Trial 19.81 90.79 22.52 20.71 40.01

Competitive Comparison of AngioLab's EV-to-Revenue

For the Biotechnology subindustry, AngioLab's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AngioLab's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AngioLab's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where AngioLab's EV-to-Revenue falls into.


AngioLab EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

AngioLab's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=15289.193/496.646
=30.78

AngioLab's current Enterprise Value is ₩15,289.2 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. AngioLab's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₩496.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AngioLab  (XKRX:251280) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

AngioLab's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=6000.00/178.265
=33.66

AngioLab's share price for today is ₩6000.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was ₩178.27.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AngioLab EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of AngioLab's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

AngioLab (XKRX:251280) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AngioLab Inc (XKRX:251280) » Definitions » EV-to-Revenue
Comparable Companies
XKRX:072520 XKRX:446440 XKRX:215380 XKRX:322970 XKRX:283100 XKRX:950220 XKRX:343090 XKRX:179530 XKRX:388610 XKRX:208340 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
65 Techno 3ro, Suite 159, Hanshin S Mecca, Yuseong-gu, Doejeon, CHN
Website
http://www.angiolab.co.kr
AngioLab Inc is a biotechnology company. It develops products based on angiogenesis inhibitors. It discovers, develops, and markets anti-angiogenic candidates to inhibit the abnormal growth of new blood vessel.

AngioLab (XKRX:251280) Headlines

No Headlines